Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Rocket Pharmaceuticals Inc shares valued at $19,688 were sold by Militello John on Aug 16 ’24. At $18.50 per share, Militello John sold 1,064 shares. The insider’s holdings dropped to 51,451 shares worth approximately $0.85 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Patel Kinnari sold 3,989 shares, netting a total of over 73,812 in proceeds. Following the sale of shares at $18.50 each, the insider now holds 396,983 shares.
Before that, Shah Gaurav had sold 9,650 shares from its account. In a trade valued at $178,564, the CEO traded Rocket Pharmaceuticals Inc shares for $18.50 each. Upon closing the transaction, the insider’s holdings decreased to 9,650 shares, worth approximately $11.89 million.
As published in their initiating research note from Goldman on April 02, 2024, Rocket Pharmaceuticals Inc [RCKT] has been a Neutral and the price target has been revised to $39. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in late October. As of February 01, 2023, Morgan Stanley has initiated its “an Overweight” rating for RCKT. Earlier on November 08, 2022, Canaccord Genuity initiated its rating. Their recommendation was “a Buy” for RCKT stock.
Analyzing RCKT Stock Performance
During the last five days, there has been a surge of approximately 3.05%. Over the course of the year, Rocket Pharmaceuticals Inc shares have dropped approximately -44.78%. Shares of the company reached a 52-week high of $31.47 on 02/27/24 and a 52-week low of $15.98 on 10/03/24. A 50-day SMA is recorded $18.85, while a 200-day SMA reached $23.74. Nevertheless, trading volume fell to 0.71 million shares from 0.72 million shares the previous day.
Support And Resistance Levels for Rocket Pharmaceuticals Inc (RCKT)
According to the 24-hour chart, there is a support level at 16.13, which, if violated, would cause prices to drop to 15.71. In the upper region, resistance lies at 16.95. The next price resistance is at 17.35. RSI (Relative Strength Index) is 39.47 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.68, which suggests the price will decrease in the coming days. Percent R is at 86.74%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
